Catalyst Wire Dossier Catalyst Wire Dossier

Cardiac Repair Cell (CRC) Treatment

ixmyelocel-t · Vericel Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cardiac Repair Cell (CRC) Treatment, covering 2021-05-27 to 2021-05-27. Get the full timeline:

Most recent: Clinical Trial Update: Use of Ixmyelocel-T (Formerly Cardiac Repair Cell [CRC] Treatment) in Patients With Heart Failure Due to Dilated Cardiomyopathy (IMPACT-DCM) [Phase 2]

See pricing